| Similar Articles |
|---|
 |
BusinessWeek
January 14, 2010
Ellen Gibson |
The Hunt for an Autism Drug Armed with fresh medical insights, drug companies are redoubling their efforts to address the disease's complex causes.   |
HHMI Bulletin
Nov 2010 |
Fusion genes that drive solid tumors are a new target for cancer therapies The success of Gleevec and related drugs has inspired researchers to step up their hunt for the molecular defects underlying other cancers. |
Nurse Practitioner
April 2010
McCravy et al. |
Speak the language of autism Autism affects 1 in 110 children and 1 in 70 boys in the United States. |
Managed Care
November 2006
Maureen Glabman |
Genetic Testing: Major Opportunity, Major Problems Whether a person is likely to develop diabetes, cancer, schizophrenia, or stroke will be reasonably well predicted, and tests can also determine whether a patient will respond to a given therapy. That's the good part. |
HHMI Bulletin
Aug 2011 |
Seeing is Believing Today, researchers are finding clever ways to deliver long-lasting, healthy genes without triggering a serious immune response. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
Popular Mechanics
February 11, 2010
Adam Hadhazy |
The Truth About 9 Anti-Vaccine Studies Led by celebrities such as Jenny McCarthy, the anti-vaccine movement continues to vehemently oppose mainstream science's overwhelming consensus that vaccines do not cause developmental disorders. |
BusinessWeek
September 5, 2005
Capell & Arndt |
Drugs Get Smart Future medicines will more effectively target what ails you by tailoring treatment to your specific genetic profile. Personalized medicine will also help prevent another Vioxx. |
Managed Care
May 2001
Michael D. Dalzell |
Powerful Opportunities For Good and Greed Genetic advances could spawn incredible improvements in health care. Given public demand, they also pose what may be unmanageable issues of resource use... |
Pharmaceutical Executive
July 1, 2011
Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
Salon.com
August 2, 2000
Lesli Mitchell |
Secrets and lies Is the astonishing rise in autism a medical mystery or a pharmaceutical shame? |
Popular Mechanics
January 2010
Amber Angelle |
How to Create a Designer Baby Women undergoing in vitro fertilization could one day choose to have a baby boy with perfect vision, an aptitude for sports and a virtual lock on avoiding colon cancer. |
Pharmaceutical Executive
October 1, 2011 |
Patient Advocacy: The Last 30 Years The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal. |
Scientific American
June 2009
Melinda Wenner |
Genetic Copy Variations and Disease A new sense for how variable numbers of genes cause disease. |
Chemistry World
July 2010
Hayley Birch |
Special Report: Health breakthroughs of the decade New discoveries have been made with cancer vaccines, genomics, statin drugs, allosteric modulators, and RNA interference during the last decade. |
Wired
December 2001
Steve Silberman |
The Geek Syndrome Autism -- and its milder cousin Asperger's syndrome -- is surging among the children of Silicon Valley. Are math-and-tech genes to blame? |
IEEE Spectrum
October 2011
Joseph M. Smith |
Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon |
Scientific American
March 2009
Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
Salon.com
May 1, 2000
Arthur Allen |
Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic. |
Pharmaceutical Executive
November 1, 2011
Elizabeth O. Coulton |
Clinical Trial Issues Not Just Black and White The selection of clinical trial participants must meld with the changing demographics of America if industry is to improve medicines that work for patients. |
BusinessWeek
April 22, 2010
Rob Waters |
Gene Therapy Takes a Turn for the Better Researchers and investors are heartened by advances in gene therapy. Analysts say revenues are still several years off, however. |
BusinessWeek
November 12, 2009
Catherine Arnst |
10 Ways to Cut Health-Care Costs Right Now Employers and hospitals don't have to wait for Congress to address inefficiencies and waste. |
Wired
February 25, 2008
David Wolman |
The Truth About Autism: Scientists Reconsider What They Think They Know The language of autism. |
Popular Mechanics
February 5, 2010
Adam Hadhazy |
Anti-Vaccination Groups Dealt Blow as Lancet Study is Retracted In what will likely be a big blow to the anti-vaccination movement, The Lancet medical journal has retracted the 1998 study by Dr. Andrew Wakefield that originally sparked the uproar over whether vaccines are linked to autism. |
Pharmaceutical Executive
September 1, 2012
Robin Hertz |
The Endless Treadmill of End-of-Life Care Bending the cost curve back to valuing the cycle of life. |
Wired
March 23, 2009
Jonah Lehrer |
Scientists Map the Brain, Gene by Gene I'm in the dissection room of the Allen Institute for Brain Science in Seattle, and the scientist next to me is in a hurry. |
Bio-IT World
March 10, 2003
Salvatore Salamone |
Common Knowledge Two heads (or more) are better than one, except when they don't share information. That's where knowledge management comes in. |
BusinessWeek
June 13, 2005
John Carey |
The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications. |
Salon.com
April 13, 2000
Arthur Allen |
Inoculated into oblivion When families hit the Capitol last week, they demanded answers about the source of their children's autism. |
Bio-IT World
June 17, 2004
Michael A. Goldman |
A Hip Approach to Gene Hunting IntegraGen defines the genetic blueprint of complex human diseases and delivers validated disease markers and therapeutic targets for a better diagnosis and a causal treatment of common diseases, based on its unique genomic analysis expertise. |
Reason
Aug/Sep 2000
Ronald Bailey |
Strands of Life Book Review: Genome: The Autobiography of a Species in 23 Chapters, by Matt Ridley |
The Motley Fool
August 20, 2011
Luke Timmerman |
Seattle Genetics Wins FDA Approval of First Drug FDA gives a quick turnaround on the new treatment for lymphomas. |
AskMen.com
October 30, 2013
Michelle Magnan |
The Difference Between Usain Bolt And You: The point that David Epstein explores at length in The Sports Gene, is that no two people respond to sports training the same way, because no two genomes are the same. |
Pharmaceutical Executive
September 1, 2012
Al Topin |
Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty. |
Wired
September 2002
Amanda Griscom |
Take These Genes and Call Me in the Morning Gene vaccines may be relatively new, but they're the logical outgrowth of two familiar strands of medical science. |
Search Engine Watch
December 31, 2010
Dean Stephens |
Health Gets Social in 2010 The role of social media in search results is influencing how health organizations attract and treat patients. |
HHMI Bulletin
Aug 2011 |
Karl Deisseroth: In Support of Undirected Research A disease focus can color the scientific process. |
BusinessWeek
March 6, 2006
Bruce Einhorn |
A Cancer Treatment You Can't Get Here China, with lower regulatory hurdles, is racing to a lead in gene therapy. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
Wired
December 2001
Oliver Morton |
Think Different? Autism researcher Simon Baron-Cohen on "mindblind" engineers, hidden pictures, and a future designed for people with Asperger's... |
Chemistry World
September 13, 2012
Ian Le Guillou |
Hope for autism treatments Two reports in Science over the past week point the way to potential treatments for some forms of autism. |
